No Data
No Data
Express News | Notable Labs Ltd Files for Offering up to 19.7 Mln Ordinary Shares and Warrants to Purchase up to 19.7 Mln of Ordinary Shares
Notable Labs Unveils Strategic Outlook in Business Update
Express News | Chardan Capital Maintains Buy on Notable Labs, Lowers Price Target to $5
Buy Rating Affirmed for Notable Labs Amid Promising Drug Program and Robust PPMP Platform
Notable Labs | 10-Q: Quarterly report
Notable Labs to Participate in Fireside Chat at the Citizens JMP Securities Life Sciences Conference 2024
No Data